Gero LLC is focused on creating first in class small molecule therapeutics using proprietary, industry-leading molecular modeling methods and systems biology technologies.

Company Overview:
Gero LLC is a drug development company based in Moscow, Russia. Our research is focused on the identification of new drugs, which could be developed to slowdown the process of aging. We have built an aging model that allows us to identify biomarkers (patterns) of aging and targets for possible interventions against aging. Also, we have oncology, diabetes and antibiotics drug candidates in our pipeline. To know more about the company, visit Gero.com.